[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Pet Vaccine Market Report 2018

January 2018 | 99 pages | ID: U2229AD9AADEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Pet Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Pet Vaccine in these regions, from 2013 to 2025 (forecast).
United States Pet Vaccine market competition by top manufacturers/players, with Pet Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Bayer Healthcare
  • Vetoquinol S.A
  • Boehringer Ingelheim
  • Ceva
  • Eli Lilly
  • Heska Co.
  • Merck Animal Health
  • Merial (Sanofi)
  • Virbac
  • Zoetis (Pfizer)
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Attenuated Live Vaccines
  • Conjugate Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • DNA Vaccines
  • Recombinant Vaccines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Canine
  • Avian
  • Feline
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Pet Vaccine Market Report 2018

1 PET VACCINE OVERVIEW

1.1 Product Overview and Scope of Pet Vaccine
1.2 Classification of Pet Vaccine by Product Category
  1.2.1 United States Pet Vaccine Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Pet Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Attenuated Live Vaccines
  1.2.4 Conjugate Vaccines
  1.2.5 Inactivated Vaccines
  1.2.6 Subunit Vaccines
  1.2.7 Toxoid Vaccines
  1.2.8 DNA Vaccines
  1.2.9 Recombinant Vaccines
1.3 United States Pet Vaccine Market by Application/End Users
  1.3.1 United States Pet Vaccine Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Canine
  1.3.3 Avian
  1.3.4 Feline
1.4 United States Pet Vaccine Market by Region
  1.4.1 United States Pet Vaccine Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Pet Vaccine Status and Prospect (2013-2025)
  1.4.3 Southwest Pet Vaccine Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Pet Vaccine Status and Prospect (2013-2025)
  1.4.5 New England Pet Vaccine Status and Prospect (2013-2025)
  1.4.6 The South Pet Vaccine Status and Prospect (2013-2025)
  1.4.7 The Midwest Pet Vaccine Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Pet Vaccine (2013-2025)
  1.5.1 United States Pet Vaccine Sales and Growth Rate (2013-2025)
  1.5.2 United States Pet Vaccine Revenue and Growth Rate (2013-2025)

2 UNITED STATES PET VACCINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Pet Vaccine Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Pet Vaccine Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Pet Vaccine Average Price by Players/Suppliers (2013-2018)
2.4 United States Pet Vaccine Market Competitive Situation and Trends
  2.4.1 United States Pet Vaccine Market Concentration Rate
  2.4.2 United States Pet Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Pet Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES PET VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Pet Vaccine Sales and Market Share by Region (2013-2018)
3.2 United States Pet Vaccine Revenue and Market Share by Region (2013-2018)
3.3 United States Pet Vaccine Price by Region (2013-2018)

4 UNITED STATES PET VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Pet Vaccine Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Pet Vaccine Revenue and Market Share by Type (2013-2018)
4.3 United States Pet Vaccine Price by Type (2013-2018)
4.4 United States Pet Vaccine Sales Growth Rate by Type (2013-2018)

5 UNITED STATES PET VACCINE SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Pet Vaccine Sales and Market Share by Application (2013-2018)
5.2 United States Pet Vaccine Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES PET VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Bayer Healthcare
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Pet Vaccine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bayer Healthcare Pet Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Vetoquinol S.A
  6.2.2 Pet Vaccine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Vetoquinol S.A Pet Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Boehringer Ingelheim
  6.3.2 Pet Vaccine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Boehringer Ingelheim Pet Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Ceva
  6.4.2 Pet Vaccine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Ceva Pet Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Eli Lilly
  6.5.2 Pet Vaccine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Eli Lilly Pet Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Heska Co.
  6.6.2 Pet Vaccine Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Heska Co. Pet Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Merck Animal Health
  6.7.2 Pet Vaccine Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Merck Animal Health Pet Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Merial (Sanofi)
  6.8.2 Pet Vaccine Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Merial (Sanofi) Pet Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Virbac
  6.9.2 Pet Vaccine Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Virbac Pet Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Zoetis (Pfizer)
  6.10.2 Pet Vaccine Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Zoetis (Pfizer) Pet Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview

7 PET VACCINE MANUFACTURING COST ANALYSIS

7.1 Pet Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Pet Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Pet Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Pet Vaccine Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES PET VACCINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Pet Vaccine Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Pet Vaccine Sales Volume Forecast by Type (2018-2025)
11.3 United States Pet Vaccine Sales Volume Forecast by Application (2018-2025)
11.4 United States Pet Vaccine Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Pet Vaccine
Figure United States Pet Vaccine Market Size (K Doses) by Type (2013-2025)
Figure United States Pet Vaccine Sales Volume Market Share by Type (Product Category) in 2017
Figure Attenuated Live Vaccines Product Picture
Figure Conjugate Vaccines Product Picture
Figure Inactivated Vaccines Product Picture
Figure Subunit Vaccines Product Picture
Figure Toxoid Vaccines Product Picture
Figure DNA Vaccines Product Picture
Figure Recombinant Vaccines Product Picture
Figure United States Pet Vaccine Market Size (K Doses) by Application (2013-2025)
Figure United States Sales Market Share of Pet Vaccine by Application in 2017
Figure Canine Examples
Table Key Downstream Customer in Canine
Figure Avian Examples
Table Key Downstream Customer in Avian
Figure Feline Examples
Table Key Downstream Customer in Feline
Figure United States Pet Vaccine Market Size (Million USD) by Region (2013-2025)
Figure The West Pet Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Pet Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Pet Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Pet Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Pet Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Pet Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Pet Vaccine Sales (K Doses) and Growth Rate (2013-2025)
Figure United States Pet Vaccine Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Pet Vaccine Market Major Players Product Sales Volume (K Doses) (2013-2018)
Table United States Pet Vaccine Sales (K Doses) of Key Players/Suppliers (2013-2018)
Table United States Pet Vaccine Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Pet Vaccine Sales Share by Players/Suppliers
Figure 2017 United States Pet Vaccine Sales Share by Players/Suppliers
Figure United States Pet Vaccine Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Pet Vaccine Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Pet Vaccine Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Pet Vaccine Revenue Share by Players/Suppliers
Figure 2017 United States Pet Vaccine Revenue Share by Players/Suppliers
Table United States Market Pet Vaccine Average Price (USD/Dose) of Key Players/Suppliers (2013-2018)
Figure United States Market Pet Vaccine Average Price (USD/Dose) of Key Players/Suppliers in 2017
Figure United States Pet Vaccine Market Share of Top 3 Players/Suppliers
Figure United States Pet Vaccine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Pet Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Pet Vaccine Product Category
Table United States Pet Vaccine Sales (K Doses) by Region (2013-2018)
Table United States Pet Vaccine Sales Share by Region (2013-2018)
Figure United States Pet Vaccine Sales Share by Region (2013-2018)
Figure United States Pet Vaccine Sales Market Share by Region in 2017
Table United States Pet Vaccine Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Pet Vaccine Revenue Share by Region (2013-2018)
Figure United States Pet Vaccine Revenue Market Share by Region (2013-2018)
Figure United States Pet Vaccine Revenue Market Share by Region in 2017
Table United States Pet Vaccine Price (USD/Dose) by Region (2013-2018)
Table United States Pet Vaccine Sales (K Doses) by Type (2013-2018)
Table United States Pet Vaccine Sales Share by Type (2013-2018)
Figure United States Pet Vaccine Sales Share by Type (2013-2018)
Figure United States Pet Vaccine Sales Market Share by Type in 2017
Table United States Pet Vaccine Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Pet Vaccine Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Pet Vaccine by Type (2013-2018)
Figure Revenue Market Share of Pet Vaccine by Type in 2017
Table United States Pet Vaccine Price (USD/Dose) by Types (2013-2018)
Figure United States Pet Vaccine Sales Growth Rate by Type (2013-2018)
Table United States Pet Vaccine Sales (K Doses) by Application (2013-2018)
Table United States Pet Vaccine Sales Market Share by Application (2013-2018)
Figure United States Pet Vaccine Sales Market Share by Application (2013-2018)
Figure United States Pet Vaccine Sales Market Share by Application in 2017
Table United States Pet Vaccine Sales Growth Rate by Application (2013-2018)
Figure United States Pet Vaccine Sales Growth Rate by Application (2013-2018)
Table Bayer Healthcare Basic Information List
Table Bayer Healthcare Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Bayer Healthcare Pet Vaccine Sales Growth Rate (2013-2018)
Figure Bayer Healthcare Pet Vaccine Sales Market Share in United States (2013-2018)
Figure Bayer Healthcare Pet Vaccine Revenue Market Share in United States (2013-2018)
Table Vetoquinol S.A Basic Information List
Table Vetoquinol S.A Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Vetoquinol S.A Pet Vaccine Sales Growth Rate (2013-2018)
Figure Vetoquinol S.A Pet Vaccine Sales Market Share in United States (2013-2018)
Figure Vetoquinol S.A Pet Vaccine Revenue Market Share in United States (2013-2018)
Table Boehringer Ingelheim Basic Information List
Table Boehringer Ingelheim Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim Pet Vaccine Sales Growth Rate (2013-2018)
Figure Boehringer Ingelheim Pet Vaccine Sales Market Share in United States (2013-2018)
Figure Boehringer Ingelheim Pet Vaccine Revenue Market Share in United States (2013-2018)
Table Ceva Basic Information List
Table Ceva Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Ceva Pet Vaccine Sales Growth Rate (2013-2018)
Figure Ceva Pet Vaccine Sales Market Share in United States (2013-2018)
Figure Ceva Pet Vaccine Revenue Market Share in United States (2013-2018)
Table Eli Lilly Basic Information List
Table Eli Lilly Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Eli Lilly Pet Vaccine Sales Growth Rate (2013-2018)
Figure Eli Lilly Pet Vaccine Sales Market Share in United States (2013-2018)
Figure Eli Lilly Pet Vaccine Revenue Market Share in United States (2013-2018)
Table Heska Co. Basic Information List
Table Heska Co. Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Heska Co. Pet Vaccine Sales Growth Rate (2013-2018)
Figure Heska Co. Pet Vaccine Sales Market Share in United States (2013-2018)
Figure Heska Co. Pet Vaccine Revenue Market Share in United States (2013-2018)
Table Merck Animal Health Basic Information List
Table Merck Animal Health Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Merck Animal Health Pet Vaccine Sales Growth Rate (2013-2018)
Figure Merck Animal Health Pet Vaccine Sales Market Share in United States (2013-2018)
Figure Merck Animal Health Pet Vaccine Revenue Market Share in United States (2013-2018)
Table Merial (Sanofi) Basic Information List
Table Merial (Sanofi) Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Merial (Sanofi) Pet Vaccine Sales Growth Rate (2013-2018)
Figure Merial (Sanofi) Pet Vaccine Sales Market Share in United States (2013-2018)
Figure Merial (Sanofi) Pet Vaccine Revenue Market Share in United States (2013-2018)
Table Virbac Basic Information List
Table Virbac Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Virbac Pet Vaccine Sales Growth Rate (2013-2018)
Figure Virbac Pet Vaccine Sales Market Share in United States (2013-2018)
Figure Virbac Pet Vaccine Revenue Market Share in United States (2013-2018)
Table Zoetis (Pfizer) Basic Information List
Table Zoetis (Pfizer) Pet Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Zoetis (Pfizer) Pet Vaccine Sales Growth Rate (2013-2018)
Figure Zoetis (Pfizer) Pet Vaccine Sales Market Share in United States (2013-2018)
Figure Zoetis (Pfizer) Pet Vaccine Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pet Vaccine
Figure Manufacturing Process Analysis of Pet Vaccine
Figure Pet Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Pet Vaccine Major Players/Suppliers in 2017
Table Major Buyers of Pet Vaccine
Table Distributors/Traders List
Figure United States Pet Vaccine Sales Volume (K Doses) and Growth Rate Forecast (2018-2025)
Figure United States Pet Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Pet Vaccine Price (USD/Dose) Trend Forecast (2018-2025)
Table United States Pet Vaccine Sales Volume (K Doses) Forecast by Type (2018-2025)
Figure United States Pet Vaccine Sales Volume (K Doses) Forecast by Type (2018-2025)
Figure United States Pet Vaccine Sales Volume (K Doses) Forecast by Type in 2025
Table United States Pet Vaccine Sales Volume (K Doses) Forecast by Application (2018-2025)
Figure United States Pet Vaccine Sales Volume (K Doses) Forecast by Application (2018-2025)
Figure United States Pet Vaccine Sales Volume (K Doses) Forecast by Application in 2025
Table United States Pet Vaccine Sales Volume (K Doses) Forecast by Region (2018-2025)
Table United States Pet Vaccine Sales Volume Share Forecast by Region (2018-2025)
Figure United States Pet Vaccine Sales Volume Share Forecast by Region (2018-2025)
Figure United States Pet Vaccine Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories